Loading...

Jae Sevelius, PhD

Title(s)Associate Professor, Medicine
SchoolSchool of Medicine
Phone415-502-1000 ext. 14622
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, San FranciscoPostdoctoral Research ScholarMedicine
    University of MissouriPhDClinical Psychology
    University of OregonPre-doctoral internship, APA-accreditedCounseling and Testing Center
    University of MissouriM.A.Gender Studies
    University of FloridaBachelor of SciencePsychology
    Collapse Awards and Honors
    Center for AIDS Prevention Studies, UCSF2010Innovative Dissemination Award
    CORO, UCSF2015UCSF CORO Faculty Leadership
    Gladstone Center for AIDS Research, UCSF2016Early Career Research Excellence Award - Behavioral Science
    CREDITS - Center for Research, Excellence, and Diversity in Team Science2017Strengthening Team Science in California
    American Psychological Association, Committee on Sexual Orientation and Gender Diversity2018Outstanding Achievement Award

    Collapse Overview 
    Collapse Overview
    I am an Associate Professor in Residence with the Center for AIDS Prevention Studies (CAPS), Division of Prevention Sciences, Department of Medicine, at the University of California, San Francisco. I lead several community-based research projects at the Center of Excellence for Transgender Health focused on leveraging data to develop culturally relevant, trauma-informed, and transgender–specific programs and interventions to promote holistic health and wellness among transgender people, with an emphasis on serving transgender women of color and those affected by HIV. I am also a licensed clinical psychologist.

    Collapse Research 
    Collapse Research Activities and Funding
    A couples-based approach to HIV prevention for transgender women and their male partners
    NIH R01MH115765Jul 15, 2018 - Apr 30, 2023
    Role: Multi-Principal Investigator
    Adapting the Sheroes intervention for transgender women in Brazil
    Research Evaluation & Allocation Committee - UCSF School of Medicine Jan 1, 2018 - Dec 31, 2018
    Role: Principal Investigator
    TRIUMPH: Trans Research-Informed communities United in Mobilization for the Prevention of HIV
    California HIV/AIDS Research Program PR15-SF-007Apr 1, 2016 - Mar 31, 2020
    Role: Principal Investigator
    Improving engagement in HIV care for high-risk women
    NIH R01MH106373Sep 8, 2015 - Jun 30, 2020
    Role: Principal Investigator
    Culturally relevant intervention development for incarcerated transgender women
    NIH R34DA038541Sep 15, 2014 - Aug 31, 2017
    Role: Principal Investigator
    SHEROES: Cuturally relevant sexual risk reduction among high-risk women
    NIH R34MH102109Sep 26, 2013 - Jun 30, 2016
    Role: Principal Investigator
    Culturally Relevant HIV Prevention for High-Risk Women
    NIH K08MH085566Jan 1, 2009 - Feb 28, 2014
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Featured Publications
    Collapse Global Health
    Collapse Websites
    Collapse In The News
    Collapse Featured Presentations
    Collapse Featured Videos

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Sevelius, J., Chakravarty, D., Neilands, T.B., Keatley, J., Shade, S.B., Johnson, M.O., Rebchook, G., HRSA SPNS Transgender Women of Color Study Group .Evidence for the Model of Gender Affirmation: The role of gender affirmation and healthcare empowerment in viral suppression among transgender women of color living with HIV. AIDS & Behavior. 2019.
    2. Gamarel, K., Sevelius, J., Reisner, S., Richardson, R., Darbes, L.A., Nemoto, T., Operario, D. .Relationship stigma, sexual identities, and HIV risk: Implications for linking and engaging cisgender men partnered with transgender women in HIV prevention effort. Archives of Sexual Behavior. 2019.
    3. George, J.R., Michaels, T.I., Sevelius, J.M., Williams, M. .The Psychedelic Renaissance and the limitations of a White-dominant medical framework. Journal of Psychedelic Studies. 2019.
    4. D’Avanzo, PA, Bass, SB, Brajuha, J, Gutierrez-Mock, L, Ventriglia, N, Wellington, C, Sevelius, J. .Medical Mistrust and PrEP Perceptions Among Transgender Women: A Cluster Analysis. Behavioral Medicine. 2019.
      View Publication
    5. Sevelius J, Murray LR, Martinez Fernandes N, Veras MA, Grinsztejn B, Lippman SA. Optimising HIV programming for transgender women in Brazil. Cult Health Sex. 2018 Oct 31; 1-15. PMID: 30378463.
      View in: PubMed
    6. Gamarel, KE, Sevelius, JM, Reisner, SL, Coats, CS, Nemoto, T, & Operario, D.Commitment, interpersonal stigma, and mental health in romantic relationships between transgender women and cisgender male partners. Journal of Social and Personal Relationships. 2018.
      View Publication
    7. Hoffkling A, Obedin-Maliver J, Sevelius J. From erasure to opportunity: a qualitative study of the experiences of transgender men around pregnancy and recommendations for providers. BMC Pregnancy Childbirth. 2017 Nov 08; 17(Suppl 2):332. PMID: 29143629.
      View in: PubMed
    8. Sevelius J, Jenness V. Challenges and opportunities for gender-affirming healthcare for transgender women in prison. Int J Prison Health. 2017 03 13; 13(1):32-40. PMID: 28299969.
      View in: PubMed
    9. Meerwijk EL, Sevelius JM. Transgender Population Size in the United States: a Meta-Regression of Population-Based Probability Samples. Am J Public Health. 2017 Feb; 107(2):216. PMID: 28075643.
      View in: PubMed
    10. Rebchook G, Keatley J, Contreras R, Perloff J, Molano LF, Reback CJ, Ducheny K, Nemoto T, Lin R, Birnbaum J, Woods T, Xavier J; SPNS Transgender Women of Color Study Group.The Transgender Women of Color Initiative: Implementing and Evaluating Innovative Interventions to Enhance Engagement and Retention in HIV Care. American Journal of Public Health. 2017.
    11. Sevelius JM, Deutsch MB, Grant R. The future of PrEP among transgender women: the critical role of gender affirmation in research and clinical practices. J Int AIDS Soc. 2016; 19(7(Suppl 6)):21105. PMID: 27760683.
      View in: PubMed
    12. Grant RM, Sevelius JM, Guanira JV, Aguilar JV, Chariyalertsak S, Deutsch MB. Transgender Women in Clinical Trials of Pre-Exposure Prophylaxis. J Acquir Immune Defic Syndr. 2016 08 15; 72 Suppl 3:S226-9. PMID: 27429187.
      View in: PubMed
    13. Radix A, Sevelius J, Deutsch MB. Transgender women, hormonal therapy and HIV treatment: a comprehensive review of the literature and recommendations for best practices. J Int AIDS Soc. 2016; 19(3 Suppl 2):20810. PMID: 27431475.
      View in: PubMed
    14. Sevelius J, Deutsch MB, Glidden DV, Grant RM. PrEP adherence among trans women in Brazil-access needed for this key population - Authors' reply. Lancet HIV. 2016 05; 3(5):e200-1. PMID: 27126486.
      View in: PubMed
    15. Pollock L, Silva-Santisteban A, Sevelius J, Salazar X. 'You should build yourself up as a whole product': Transgender female identity in Lima, Peru. Glob Public Health. 2016 Aug-Sep; 11(7-8):981-93. PMID: 27080150.
      View in: PubMed
    16. Safer JD, Coleman E, Feldman J, Garofalo R, Hembree W, Radix A, Sevelius J. Barriers to healthcare for transgender individuals. Curr Opin Endocrinol Diabetes Obes. 2016 Apr; 23(2):168-71. PMID: 26910276; PMCID: PMC4802845 [Available on 04/01/17].
      View in: PubMed, PubMed Central
    17. Bockting W, Coleman E, Deutsch MB, Guillamon A, Meyer I, Meyer W, Reisner S, Sevelius J, Ettner R. Adult development and quality of life of transgender and gender nonconforming people. Curr Opin Endocrinol Diabetes Obes. 2016 Apr; 23(2):188-97. PMID: 26835800.
      View in: PubMed
    18. Lippman SA, Moran L, Sevelius J, Castillo LS, Ventura A, Treves-Kagan S, Buchbinder S. Acceptability and Feasibility of HIV Self-Testing Among Transgender Women in San Francisco: A Mixed Methods Pilot Study. AIDS Behav. 2016 Apr; 20(4):928-38. PMID: 26511864; PMCID: PMC4799740 [Available on 04/01/17].
      View in: PubMed, PubMed Central
    19. Sevelius JM, Keatley J, Calma N, Arnold E. 'I am not a man': Trans-specific barriers and facilitators to PrEP acceptability among transgender women. Glob Public Health. 2016 Aug-Sep; 11(7-8):1060-75. PMID: 26963756.
      View in: PubMed
    20. Kaplan RL, Sevelius J, Ribeiro K. In the name of brevity: The problem with binary HIV risk categories. Glob Public Health. 2016 Aug-Sep; 11(7-8):824-34. PMID: 26824592.
      View in: PubMed
    21. Deutsch MB, Glidden DV, Sevelius J, Keatley J, McMahan V, Guanira J, Kallas EG, Chariyalertsak S, Grant RM. HIV pre-exposure prophylaxis in transgender women: a subgroup analysis of the iPrEx trial. Lancet HIV. 2015 Dec; 2(12):e512-9. PMID: 26614965.
      View in: PubMed
    22. Reisner SL, White Hughto JM, Pardee D, Sevelius J. Syndemics and gender affirmation: HIV sexual risk in female-to-male trans masculine adults reporting sexual contact with cisgender males. Int J STD AIDS. 2016 10; 27(11):955-66. PMID: 26384946; PMCID: PMC4798921 [Available on 10/01/16].
      View in: PubMed, PubMed Central
    23. Light AD, Obedin-Maliver J, Sevelius JM, Kerns JL. Transgender men who experienced pregnancy after female-to-male gender transitioning. Obstet Gynecol. 2014 Dec; 124(6):1120-7. PMID: 25415163.
      View in: PubMed
    24. Deutsch MB, Keatley J, Sevelius J, Shade SB. Collection of gender identity data using electronic medical records: survey of current end-user practices. J Assoc Nurses AIDS Care. 2014 Nov-Dec; 25(6):657-63. PMID: 24880490.
      View in: PubMed
    25. Sevelius JM, Saberi P, Johnson MO. Correlates of antiretroviral adherence and viral load among transgender women living with HIV. AIDS Care. 2014; 26(8):976-82. PMID: 24646419; PMCID: PMC4054817.
      View in: PubMed, PubMed Central
    26. Sevelius JM, Patouhas E, Keatley JG, Johnson MO. Barriers and facilitators to engagement and retention in care among transgender women living with human immunodeficiency virus. Ann Behav Med. 2014 Feb; 47(1):5-16. PMID: 24317955.
      View in: PubMed
    27. Reisner SL, Bailey Z, Sevelius J. Racial/ethnic disparities in history of incarceration, experiences of victimization, and associated health indicators among transgender women in the U.S. Women Health. 2014; 54(8):750-67. PMID: 25190135.
      View in: PubMed
    28. Sevelius JM. Gender Affirmation: A Framework for Conceptualizing Risk Behavior among Transgender Women of Color. Sex Roles. 2013 Jun 01; 68(11-12):675-689. PMID: 23729971.
      View in: PubMed
    29. Jefferson, K., Neilands, T.b., Sevelius, J.Transgender women of color: Discrimination and depression symptoms. Ethnicity and Inequalities in Health and Social Care. 2013; 6(4):121-136.
    30. Jefferson K, Neilands TB, Sevelius J. Transgender women of color: discrimination and depression symptoms. Ethn Inequal Health Soc Care. 2013; 6(4):121-136. PMID: 25346778.
      View in: PubMed
    31. Johnson MO, Sevelius JM, Dilworth SE, Saberi P, Neilands TB. Preliminary support for the construct of health care empowerment in the context of treatment for human immunodeficiency virus. Patient Prefer Adherence. 2012; 6:395-404. PMID: 22654510; PMCID: PMC3363300.
      View in: PubMed, PubMed Central
    32. Sevelius JM, Keatley J, Gutierrez-Mock L. HIV/AIDS programming in the United States: considerations affecting transgender women and girls. Womens Health Issues. 2011 Nov; 21(6 Suppl):S278-82. PMID: 22055679.
      View in: PubMed
    33. Sevelius JM, Carrico A, Johnson MO. Antiretroviral therapy adherence among transgender women living with HIV. J Assoc Nurses AIDS Care. 2010 May-Jun; 21(3):256-64. PMID: 20347342; PMCID: PMC2859994.
      View in: PubMed, PubMed Central
    34. Sevelius J. "There's no pamphlet for the kind of sex I have": HIV-related risk factors and protective behaviors among transgender men who have sex with nontransgender men. J Assoc Nurses AIDS Care. 2009 Sep-Oct; 20(5):398-410. PMID: 19732698; PMCID: PMC2785444.
      View in: PubMed, PubMed Central
    35. Sevelius JM, Reznick OG, Hart SL, Schwarcz S. Informing interventions: the importance of contextual factors in the prediction of sexual risk behaviors among transgender women. AIDS Educ Prev. 2009 Apr; 21(2):113-27. PMID: 19397434; PMCID: PMC4535696.
      View in: PubMed, PubMed Central
    36. Stake, J.E., Sevelius, J.M., Hanly, S. .Student responsiveness to women's and gender studies classes: The importance of initial student attitudes and classroom relationships. NWSA Journal. 2008; 2(20):189-215.
    37. Operario D, Burton J, Underhill K, Sevelius J. Men who have sex with transgender women: challenges to category-based HIV prevention. AIDS Behav. 2008 Jan; 12(1):18-26. PMID: 17705095.
      View in: PubMed
    38. Sevelius, J.M. & Stake, J.E. .The effects of prior attitudes and attitude importance on attitude change and class impact in women’s and gender studies. Journal of Applied Social Psychology. 2003; (33):2341 – 2353.
    Jae's Networks
    Concepts
    Derived automatically from this person's publications.
    See all (132) concept(s)
    _
    Co-Authors
    People in Profiles who have published with this person.
    See all (13) people
    _
    Similar People
    People who share similar concepts with this person.
    See all (60) people
    _
    Same Department
    Search Department
    ↑